Scholars Central

Conference abstractPublished 2021

Pharmacovigilance business continuity during COVID emergency: Italian case

Authors: Francesca Rollo

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

COVID-19 emergency started from China but the pandemic status was been defined after the “patient 0” identified in Italy. After the 25th February 2020 the situation of infection run fast and most of the company decided to close their offices and start the smartworking. The rapid change in the daily routine has an important impact on the socio-economic life but also for the pharmaceutical company. The pharmacovigilance department is deeply impacted by the COVID-19 emergency and the actions/decisions that have been taken should be effective and immediate. Aim of this speech is to present the approach of Italian pharmacovigilance team to the management of daily activities in order to ensure business continuity and pharmacovigilance requirements. In particular it will be describe how the Viatris Italian pharmacovigilance affiliate change the daily routine from the communication that the office are close and all employees started to work from home.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Francesca Rollo”